US EditionPublished • loading... • Updated
Galapagos Spinout Coultreon Raises $125M for New Take on SIK Inhibition
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
15:55 A study that ended up in a forgotten corner at Galapagos is emerging as an investor magnet. Leuven-based Coultreon Biopharma raises 125 million dollars for the search for a new me...
·Belgium
Read Full Article
Galapagos spinout Coultreon raises $125M for new take on SIK inhibition
Coultreon Biopharma has patched together $125 million from some of the largest biotech investors in the US and Europe in a bid to join the burgeoning pipeline-in-a-pill approach to autoimmune diseases. The Tuesday morning Series ...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
